Time to give up on biosims, experts say. Price regulations would deliver more savings

18th April 2019 Uncategorised 0

Biosimilar drugs aren’t working to cut drug costs, experts say. Instead, it’s time to control prices on biologics after the drugs lose exclusivity.

More: Time to give up on biosims, experts say. Price regulations would deliver more savings
Source: fierce